Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Fractures: Bone Repair01:27

Fractures: Bone Repair

4.9K
Treatment for a fracture is based on the type of break, the bone affected, and the patient's age.
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
4.9K
Cancer Therapies02:49

Cancer Therapies

9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Bone Disorders01:29

Bone Disorders

5.0K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.0K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

176
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
176
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

195
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
195

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immunotherapy in pediatric bone sarcomas: Current progress and future directions.

Human vaccines & immunotherapeutics·2026
Same author

Prolonged Survival With Homozygous Deletion of Exon 9 in Perlman Syndrome: A Case Report.

Case reports in genetics·2026
Same author

Single-Cell RNA Analysis of Murine Osteosarcoma Uncovers Skp2 Function in Metastasis, Genomic Instability, and Immune Activation and Reveals Additional Target Pathways.

Cancer research communications·2026
Same author

Treatment strategies for relapsed medulloblastoma in the pediatric population: illustrative case.

Journal of neurosurgery. Case lessons·2026
Same author

Cycling molecular assemblies for Golgi imaging and disruption.

Nature communications·2026
Same author

Stereotactic Body Radiation Therapy for Pediatric, Adolescent, and Young Adult Patients With Osteosarcoma: Local Control Outcomes With Dosimetric Analysis.

Pediatric blood & cancer·2026

Related Experiment Video

Updated: Jan 9, 2026

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
09:25

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

19.6K

Management of pediatric bone sarcomas.

Leighton Elliott1, David M Loeb2, Matteo Trucco3

  • 1Department of Medicine and Pediatrics, University of Florida College of Medicine, UF Health Cancer Center, Gainesville, FL.

Current Opinion in Pediatrics
|December 9, 2025
PubMed
Summary
This summary is machine-generated.

Outcomes for children with metastatic or relapsed bone sarcomas have stagnated. New strategies combining tyrosine kinase inhibitors with chemotherapy and improved risk stratification show promise for better pediatric cancer treatment.

Keywords:
Ewing sarcomactDNAosteosarcomapediatric bone sarcomapulmonary metastasectomysurvivorshiptyrosine kinase inhibitor

More Related Videos

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.9K
Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
04:25

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

11.1K

Related Experiment Videos

Last Updated: Jan 9, 2026

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
09:25

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

19.6K
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.9K
Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
04:25

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

11.1K

Area of Science:

  • Pediatric Oncology
  • Skeletal System Neoplasms
  • Cancer Therapeutics

Background:

  • Localized pediatric bone sarcomas (osteosarcoma and Ewing sarcoma) are often curable, but outcomes for metastatic or relapsed cases remain poor.
  • Current frontline therapies for osteosarcoma and Ewing sarcoma have not significantly advanced in decades.
  • Emerging technologies like circulating tumor DNA (ctDNA) offer potential for improved diagnosis and risk stratification.

Purpose of the Study:

  • To synthesize recent clinically relevant developments in the diagnosis, risk stratification, local control, systemic therapy, and survivorship of pediatric bone sarcomas.
  • To review advancements informing treatment strategies for osteosarcoma and Ewing sarcoma in children and adolescents.
  • To highlight challenges and future directions in managing pediatric bone cancers.

Main Methods:

  • Literature review of recent clinical developments and ongoing research in pediatric bone sarcoma.
  • Synthesis of data on diagnostic tools, therapeutic approaches, and survivorship care.
  • Analysis of emerging technologies and clinical trial outcomes.

Main Results:

  • Standard frontline therapies for osteosarcoma and Ewing sarcoma remain unchanged.
  • Circulating tumor DNA (ctDNA) shows promise for validating and incorporating into treatment regimens.
  • Tyrosine kinase inhibitor-chemotherapy combinations are a current strategy to improve upfront therapy, with novel drug combinations being tested.
  • Debate continues regarding optimal surgical approaches for pulmonary metastasectomy in osteosarcoma.

Conclusions:

  • While single-agent checkpoint inhibitors have shown limited efficacy, rational tyrosine kinase inhibitor-chemotherapy combinations, improved biologic risk stratification (ctDNA, MYC, STAG2), and standardized local control are reshaping care.
  • Near-term priorities include biomarker-anchored upfront trials and supportive care to reduce late effects.
  • Clinical trials are crucial for accessing potentially paradigm-shifting therapeutic strategies for pediatric bone tumors.